PL3033103T3 - Sposoby poprawy objawów astmy przy zastosowaniu benralizumabu - Google Patents
Sposoby poprawy objawów astmy przy zastosowaniu benralizumabuInfo
- Publication number
- PL3033103T3 PL3033103T3 PL14836392T PL14836392T PL3033103T3 PL 3033103 T3 PL3033103 T3 PL 3033103T3 PL 14836392 T PL14836392 T PL 14836392T PL 14836392 T PL14836392 T PL 14836392T PL 3033103 T3 PL3033103 T3 PL 3033103T3
- Authority
- PL
- Poland
- Prior art keywords
- benralizumab
- methods
- asthma symptoms
- improving asthma
- improving
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361864950P | 2013-08-12 | 2013-08-12 | |
| PCT/US2014/050122 WO2015023508A2 (en) | 2013-08-12 | 2014-08-07 | Methods for improving asthma symptoms using benralizumab |
| EP14836392.2A EP3033103B1 (en) | 2013-08-12 | 2014-08-07 | Methods for improving asthma symptoms using benralizumab |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3033103T3 true PL3033103T3 (pl) | 2019-10-31 |
Family
ID=52448839
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL19162585T PL3536339T3 (pl) | 2013-08-12 | 2014-08-07 | Sposoby poprawy objawów astmy przy zastosowaniu benralizumabu |
| PL14836392T PL3033103T3 (pl) | 2013-08-12 | 2014-08-07 | Sposoby poprawy objawów astmy przy zastosowaniu benralizumabu |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL19162585T PL3536339T3 (pl) | 2013-08-12 | 2014-08-07 | Sposoby poprawy objawów astmy przy zastosowaniu benralizumabu |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US9441047B2 (pl) |
| EP (3) | EP3536339B1 (pl) |
| JP (2) | JP6803229B2 (pl) |
| KR (1) | KR102337601B1 (pl) |
| CN (2) | CN105451761A (pl) |
| AU (3) | AU2014306960B2 (pl) |
| BR (1) | BR112016002462A8 (pl) |
| CA (1) | CA2918050C (pl) |
| DK (2) | DK3033103T3 (pl) |
| ES (2) | ES2901634T3 (pl) |
| HK (1) | HK1221647A1 (pl) |
| HU (2) | HUE045402T2 (pl) |
| MX (1) | MX368474B (pl) |
| PL (2) | PL3536339T3 (pl) |
| RU (1) | RU2728578C2 (pl) |
| SG (1) | SG11201600484TA (pl) |
| TR (1) | TR201910413T4 (pl) |
| WO (1) | WO2015023508A2 (pl) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE043497T2 (hu) | 2013-08-12 | 2019-08-28 | Astrazeneca Ab | Módszerek a kényszerített kilégzési térfogat növelésére asztmásoknál benralizumab használatával |
| LT3033101T (lt) * | 2013-08-12 | 2019-03-25 | Astrazeneca Ab | Astmos paūmejimo dažnio sumažinimo būdai naudojant benralizumabą |
| CN113230399A (zh) * | 2013-10-15 | 2021-08-10 | 阿斯利康(瑞典)有限公司 | 用于使用贝那利珠单抗治疗慢性阻塞性肺疾病的方法 |
| CN113350278B (zh) | 2013-10-24 | 2023-03-24 | 阿斯利康(瑞典)有限公司 | 稳定的水性抗体配制品 |
| CA3002761A1 (en) | 2015-11-04 | 2017-05-11 | Astrazeneca Ab | Dipeptidyl peptidase-4 and periostin as predictors of clinical response to eosinophil-targeted therapeutic agents in eosinophilic diseases |
| US20180056018A1 (en) * | 2016-08-31 | 2018-03-01 | Cephalon, Inc. | Inhalation Systems, Devices and Methods |
| TW202214692A (zh) * | 2020-06-05 | 2022-04-16 | 瑞典商阿斯特捷利康公司 | 治療患有鼻瘜肉的患者的重度氣喘之方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU690474B2 (en) | 1995-09-11 | 1998-04-23 | Kyowa Hakko Kirin Co., Ltd. | Antibody againts alpha-chain of human interleukin 5 receptor |
| US6746839B1 (en) * | 1998-01-12 | 2004-06-08 | Interleukin Genetics, Inc. | Diagnostics and therapeutics for an obstructive airway disease |
| PT1176195E (pt) | 1999-04-09 | 2013-07-18 | Kyowa Hakko Kirin Co Ltd | Processo para controlar a actividade de uma molécula funcional sob o ponto de vista imunológico |
| US7404953B2 (en) | 2000-02-15 | 2008-07-29 | Kyowa Hakko Kogyo Co., Ltd. | Methods using eosinophil-specific apoptosis inducer |
| US6946292B2 (en) | 2000-10-06 | 2005-09-20 | Kyowa Hakko Kogyo Co., Ltd. | Cells producing antibody compositions with increased antibody dependent cytotoxic activity |
| US7662925B2 (en) | 2002-03-01 | 2010-02-16 | Xencor, Inc. | Optimized Fc variants and methods for their generation |
| US20070148170A1 (en) | 2005-10-03 | 2007-06-28 | Desjarlais John R | Fc Variants With Optimized Fc Receptor Binding Properties |
| AU2004279740A1 (en) | 2003-10-08 | 2005-04-21 | Kyowa Hakko Kirin Co., Ltd. | Antibody composition specifically binding to IL-5 receptor |
| US20060014680A1 (en) | 2004-07-13 | 2006-01-19 | Caiding Xu | Peptides and compounds that bind to the IL-5 receptor |
| DK3072525T3 (en) * | 2007-05-14 | 2018-04-30 | Astrazeneca Ab | PROCEDURES FOR REDUCING BASOFILE CELL LEVELS |
| EP2652498B1 (en) * | 2010-12-16 | 2018-04-18 | F.Hoffmann-La Roche Ag | Diagnosis and treatments relating to th2 inhibition |
| EP2710370A4 (en) * | 2011-05-18 | 2015-01-07 | Medimmune Llc | METHODS OF DIAGNOSING AND TREATING PULMONARY DISEASES OR DISORDERS |
| JP2014533246A (ja) | 2011-11-01 | 2014-12-11 | メディミューン，エルエルシー | 喘息の急性増悪の頻度および重症度を低下させる方法 |
| LT3033101T (lt) * | 2013-08-12 | 2019-03-25 | Astrazeneca Ab | Astmos paūmejimo dažnio sumažinimo būdai naudojant benralizumabą |
| HUE043497T2 (hu) | 2013-08-12 | 2019-08-28 | Astrazeneca Ab | Módszerek a kényszerített kilégzési térfogat növelésére asztmásoknál benralizumab használatával |
-
2014
- 2014-08-07 TR TR2019/10413T patent/TR201910413T4/tr unknown
- 2014-08-07 RU RU2016108734A patent/RU2728578C2/ru active
- 2014-08-07 ES ES19162585T patent/ES2901634T3/es active Active
- 2014-08-07 CN CN201480044052.7A patent/CN105451761A/zh active Pending
- 2014-08-07 HU HUE14836392A patent/HUE045402T2/hu unknown
- 2014-08-07 AU AU2014306960A patent/AU2014306960B2/en active Active
- 2014-08-07 EP EP19162585.4A patent/EP3536339B1/en active Active
- 2014-08-07 US US14/454,149 patent/US9441047B2/en active Active
- 2014-08-07 ES ES14836392T patent/ES2740355T3/es active Active
- 2014-08-07 SG SG11201600484TA patent/SG11201600484TA/en unknown
- 2014-08-07 WO PCT/US2014/050122 patent/WO2015023508A2/en not_active Ceased
- 2014-08-07 EP EP14836392.2A patent/EP3033103B1/en active Active
- 2014-08-07 KR KR1020167006565A patent/KR102337601B1/ko active Active
- 2014-08-07 EP EP21188229.5A patent/EP3988114A1/en not_active Withdrawn
- 2014-08-07 CA CA2918050A patent/CA2918050C/en active Active
- 2014-08-07 PL PL19162585T patent/PL3536339T3/pl unknown
- 2014-08-07 BR BR112016002462A patent/BR112016002462A8/pt not_active Application Discontinuation
- 2014-08-07 JP JP2016534616A patent/JP6803229B2/ja active Active
- 2014-08-07 MX MX2016001195A patent/MX368474B/es active IP Right Grant
- 2014-08-07 HU HUE19162585A patent/HUE057065T2/hu unknown
- 2014-08-07 PL PL14836392T patent/PL3033103T3/pl unknown
- 2014-08-07 DK DK14836392.2T patent/DK3033103T3/da active
- 2014-08-07 DK DK19162585.4T patent/DK3536339T3/da active
- 2014-08-07 HK HK16109789.8A patent/HK1221647A1/zh unknown
- 2014-08-07 CN CN202010449449.1A patent/CN111617244A/zh active Pending
-
2020
- 2020-02-28 JP JP2020032499A patent/JP2020100653A/ja not_active Withdrawn
- 2020-04-16 AU AU2020202564A patent/AU2020202564A1/en not_active Abandoned
-
2023
- 2023-08-10 AU AU2023214323A patent/AU2023214323A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201506401B (en) | Process for producing hydrocarbons | |
| IL235512A0 (en) | New methods | |
| PT3083958T (pt) | Métodos de integração genómica | |
| GB201217018D0 (en) | Methods | |
| PL3019577T3 (pl) | Sposób wytwarzania węglowodorów | |
| SG11201600481UA (en) | Methods for reducing exacerbation rates of asthma using benralizumab | |
| GB2473409B (en) | Cloud-based de-duplication | |
| GB201700075D0 (en) | Methods to reduce gas carry-uder for cyclonic seperators | |
| SG11201600484TA (en) | Methods for improving asthma symptoms using benralizumab | |
| SG11201601807XA (en) | Methods for treating chronic obstructive pulmonary disease using benralizumab | |
| GB201208874D0 (en) | Methods | |
| GB2507760B (en) | Methods | |
| GB201219816D0 (en) | Improving local context search results | |
| PL2805796T3 (pl) | Sposób szlifowania | |
| PT2914574T (pt) | Processo novo | |
| GB201322992D0 (en) | New Process | |
| GB201204280D0 (en) | Methods | |
| GB201317756D0 (en) | New process | |
| GB201313211D0 (en) | New process | |
| GB201209689D0 (en) | Methods | |
| GB201316651D0 (en) | Asthma | |
| GB201220686D0 (en) | Methods | |
| GB201208963D0 (en) | Methods | |
| GB201208756D0 (en) | Methods | |
| TWI562827B (en) | Method for making adsorbent |